Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-World Betaseron® Outcomes Study (ROBUST): A Twelve-month, US Prospective, Observational, Open-label, Single-arm, Multi-center Outcomes Study of Interferon β-1b (Betaseron®) Given Every Other Day for Relapsing Forms of Multiple Sclerosis

NCT01158183 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01158183
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01158183 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-World Betaseron® Outcomes Study (ROBUST): A Twelve-month, US Prospective, Observational, Open-label, Single-arm, Multi-center Outcomes Study of Interferon β-1b (Betaseron®) Given Every Other Day for Relapsing Forms of Multiple Sclerosis
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
July 31, 2007
Completion date
September 30, 2009
Enrollment
226 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis, relapsing-remitting